If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 31 - 40 of 263
Assessment of Cardiovascular Risk in Inflammatory Bowel Disease Patients
Cardiovascular Risk in IBD
Protocol No
GI-IIT-SINH-CV-IN-IBD
Categories
A Screening Protocol to Determine Tumor Antigen Expression and HLA Sub-Type for Eligibility Determination for Clinical Trials Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs in Subjects with Solid or Hematological Ma
Screening Protocol for Tumor Antigen Expression Profiling and HLA typing for Eligibility
Protocol No
ADP-0000-001-SCR
Categories
Cancer,
Gynecologic Cancers,
Prostate and Urologic Cancers,
Other Respiratory,
Lung,
Esophagus,
Other Skin,
Melanoma, Skin,
Other Urologic,
Bladder,
Lip, Oral Cavity and Pharynx,
Larynx,
Other Gynecologic,
Ovary,
Thoracic Cancers,
Sarcoma,
Skin Cancers,
Head and Neck Cancers,
Gastrointestinal Cancers,
Cervix,
Other Gastrointestinal,
Stomach,
Pancreas/Liver,
Esophagus,
Colorectal
A Multisite, Phase II Study of Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory MM
Protocol No
IIT-DHAKAL-IMPEDE-SGZ-12356
Categories
A Phase II Trial of De-escalated PTCy and Ruxolitinib for GVHD Prophylaxis in Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT
A Phase 2 Trial of PTCy and Ruxolitinib for GVHD Prophylaxis in Patients Undergoing Allogenic HCT
Protocol No
IIT-ABEDIN-PTCY-RUX-GVHD
Categories
SAkuraPEAK: A Phase 1, Multicenter, Open-Label, Uncontrolled Study to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Satralizumab in Adult Patients with AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder with Body
Satralizumab in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder
Protocol No
NEURO-GENENTECH-SAKURAPEAK
Phase II Study Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma (PRORADGLIO Study)
This project is being done to to assess the efficacy of substituting Pulsed Reduced Dose
Radiotherapy (pRDR) for standard radiation therapy in the treatment of Glioblastoma
(GBM).
Radiotherapy (pRDR) for standard radiation therapy in the treatment of Glioblastoma
(GBM).
Protocol No
IIT-STRAZA-PRORADGLIO
Categories
Examination of Motor Unit Alterations in Acute and Subacute Stroke
Motor Unit Alterations in Acute and Subacute Stroke
Protocol No
NEURO-IIT-LI-MOTOR-UNIT-ALT
Categories
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
Rifaximin SSD for the Delay of Encephalopathy Decompensation in Cirrhosis
Protocol No
GI-SALIX-RNLC3131
Categories
Identifying Gut Microbiome Mediated Mechanisms for Diastolic Dysfunction Improvement After Bariatric Surgery
Identifying Gut Mechanisms to Improve Heart Failure after Bariatric Surgery
Protocol No
SURG-IIT-NHLBI-HFPEF-POST-BARI